Will the Canopy Growth Corp. (TSX:WEED) Rally Go Up in Smoke?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is in the midst of a massive, unprecedented rally. But will it continue for long?

| More on:

Last month, news that Constellation Brands Inc. (NYSE:STZ) had purchased 38% of Canopy Growth Corp (TSX:WEED)(NYSE:CGC) started a massive rally in Canopy shares. Trading at $32 at the start of the month, they were at 59.64 at the end of August. That’s a whopping 86% gain in just a few weeks!

If you had bought shares in Canopy Growth and held them until now, you’d be sitting pretty.

But is it still wise to get in today?

While the stock is very hot right now, it might not be a great long-term play, and the main reason might surprise you.

To explain what I mean, I first need to ask a question that few are willing to ask.

Is legalization actually good for cannabis stocks?

On the surface, this seems like a silly question. Legalization will increase legal cannabis sales dramatically. It will take revenue that’s currently going to the black market and divert it to publicly traded companies. It will reduce the regulatory issues that cannabis companies currently face (e.g., Health Canada guidelines and prescription checking). How could any of this be a bad thing?

Believe it or not, it could be.

Precisely because the recreational market is less regulated, it could actually drive cannabis companies’ margins down. In many jurisdictions where cannabis has been legalized, the price of cannabis has fallen as a result. This would probably be bad news for cannabis companies, most of which already have negative earnings.

Cost of revenue is a massive issue for these companies. If legalization drives prices down, then it could become an even bigger problem. And this is an issue that disproportionately affects Canopy, whose costs are rapidly mounting.

So far, I’ve outlined a sector-wide problem that may or may not impact Canopy. This alone merits taking a critical look at Canopy shares. However, there is another factor that’s specific to Canopy that may cause even more problems for the company.

Dilution of equity

When Constellation purchased its Canopy shares, it bought them direct from the company, not on the stock market. This means that the purchase will create new shares and dilute each shareholder’s percentage of ownership in the company. It will also add about $4.5 billion to the company’s assets, which will offset the dilution in the short term but it remains to be seen whether the company will use the new funds profitably.

Canopy’s plan is to spend the money on international expansion. It wants to become the #1 supplier in 11 of the countries in which it operates. If successful, this will no doubt increase Canopy’s revenue. However, Canopy’s main issue is not revenue but bottom line earnings: the company has a negative net income, and the loss grows larger every quarter. Increasing the company’s international footprint won’t help that.

What the company needs is a way to improve its margins. R&D investments, especially in areas like new cultivation, storage and distribution techniques, could help here. The company doesn’t seem to be investing much in these areas, instead focusing on growing sales (at a high cost). As a result, Canopy is vulnerable to possible downward pressure on prices in the era of legalization. If that happens, the rally we’re now witnessing may indeed go up in smoke.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »